Nabriva Therapeutics plc Gains 39.41%

Nabriva Therapeutics plc (NBRV:NASDAQ) soared at $0.27, representing a gain of 39.4%. On Thu, Sep 15, 2022, NBRV:NASDAQ touched a New 2-Week High of $0.27. The stock appeared on our News Catalysts scanner on Thu, Sep 15, 2022 at 07:57 AM in the 'SPLIT' category. From Thu, Sep 01, 2022, the stock recorded 33.33% Up Days and 10.00% Green Days

The stock spiked on Thu, Sep 15, 2022 at $0.34 with a volume of 102M+.

About Nabriva Therapeutics plc (NBRV:NASDAQ)

Nabriva Therapeutics AG is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.